The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Blood-Brain Barrier

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Blood-Brain Barrier


Psychiatry related information on Blood-Brain Barrier


High impact information on Blood-Brain Barrier


Chemical compound and disease context of Blood-Brain Barrier


Biological context of Blood-Brain Barrier


Anatomical context of Blood-Brain Barrier


Associations of Blood-Brain Barrier with chemical compounds


Gene context of Blood-Brain Barrier


Analytical, diagnostic and therapeutic context of Blood-Brain Barrier


  1. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Wang, X., Lee, S.R., Arai, K., Lee, S.R., Tsuji, K., Rebeck, G.W., Lo, E.H. Nat. Med. (2003) [Pubmed]
  2. Homeostasis during hypoglycemia: central control of adrenal secretion and peripheral control of feeding. Stricker, E.M., Rowland, N., Saller, C.F., Friedman, M.I. Science (1977) [Pubmed]
  3. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor. Heiss, J.D., Papavassiliou, E., Merrill, M.J., Nieman, L., Knightly, J.J., Walbridge, S., Edwards, N.A., Oldfield, E.H. J. Clin. Invest. (1996) [Pubmed]
  4. Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat. Wispelwey, B., Lesse, A.J., Hansen, E.J., Scheld, W.M. J. Clin. Invest. (1988) [Pubmed]
  5. The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin. Engelhardt, B., Laschinger, M., Schulz, M., Samulowitz, U., Vestweber, D., Hoch, G. J. Clin. Invest. (1998) [Pubmed]
  6. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. Cirrito, J.R., Deane, R., Fagan, A.M., Spinner, M.L., Parsadanian, M., Finn, M.B., Jiang, H., Prior, J.L., Sagare, A., Bales, K.R., Paul, S.M., Zlokovic, B.V., Piwnica-Worms, D., Holtzman, D.M. J. Clin. Invest. (2005) [Pubmed]
  7. Reversal of dementia associated with Whipple's disease by trimethoprim-sulfamethoxazole, drugs that penetrate the blood-brain barrier. Ryser, R.J., Locksley, R.M., Eng, S.C., Dobbins, W.O., Schoenknecht, F.D., Rubin, C.E. Gastroenterology (1984) [Pubmed]
  8. Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients. Marangell, L.B., George, M.S., Callahan, A.M., Ketter, T.A., Pazzaglia, P.J., L'Herrou, T.A., Leverich, G.S., Post, R.M. Arch. Gen. Psychiatry (1997) [Pubmed]
  9. Diet and Parkinson's disease. I: A possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study. Hellenbrand, W., Seidler, A., Boeing, H., Robra, B.P., Vieregge, P., Nischan, P., Joerg, J., Oertel, W.H., Schneider, E., Ulm, G. Neurology (1996) [Pubmed]
  10. Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats. Bakshi, V.P., Tricklebank, M., Neijt, H.C., Lehmann-Masten, V., Geyer, M.A. J. Pharmacol. Exp. Ther. (1999) [Pubmed]
  11. Angiotensin, thirst, and sodium appetite. Fitzsimons, J.T. Physiol. Rev. (1998) [Pubmed]
  12. moody encodes two GPCRs that regulate cocaine behaviors and blood-brain barrier permeability in Drosophila. Bainton, R.J., Tsai, L.T., Schwabe, T., DeSalvo, M., Gaul, U., Heberlein, U. Cell (2005) [Pubmed]
  13. GPCR signaling is required for blood-brain barrier formation in drosophila. Schwabe, T., Bainton, R.J., Fetter, R.D., Heberlein, U., Gaul, U. Cell (2005) [Pubmed]
  14. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Seidner, G., Alvarez, M.G., Yeh, J.I., O'Driscoll, K.R., Klepper, J., Stump, T.S., Wang, D., Spinner, N.B., Birnbaum, M.J., De Vivo, D.C. Nat. Genet. (1998) [Pubmed]
  15. Inhibition of leukocyte-endothelial cell interactions and inflammation by peptides from a bacterial adhesin which mimic coagulation factor X. Rozdzinski, E., Sandros, J., van der Flier, M., Young, A., Spellerberg, B., Bhattacharyya, C., Straub, J., Musso, G., Putney, S., Starzyk, R. J. Clin. Invest. (1995) [Pubmed]
  16. Increased brain uptake of gamma-aminobutyric acid in a rabbit model of hepatic encephalopathy. Bassett, M.L., Mullen, K.D., Scholz, B., Fenstermacher, J.D., Jones, E.A. Gastroenterology (1990) [Pubmed]
  17. Cyclosporin, blood-brain barrier, and multiple sclerosis. Fazakerley, J.K., Webb, H.E. Lancet (1985) [Pubmed]
  18. The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy. Basile, A.S., Saito, K., al-Mardini, H., Record, C.O., Hughes, R.D., Harrison, P., Williams, R., Li, Y., Heyes, M.P. Gastroenterology (1995) [Pubmed]
  19. Aluminium increases permeability of the blood-brain barrier to labelled DSIP and beta-endorphin: possible implications for senile and dialysis dementia. Banks, W.A., Kastin, A.J. Lancet (1983) [Pubmed]
  20. High-throughput screening in drug metabolism and pharmacokinetic support of drug discovery. White, R.E. Annu. Rev. Pharmacol. Toxicol. (2000) [Pubmed]
  21. Upregulation of the low density lipoprotein receptor at the blood-brain barrier: intercommunications between brain capillary endothelial cells and astrocytes. Dehouck, B., Dehouck, M.P., Fruchart, J.C., Cecchelli, R. J. Cell Biol. (1994) [Pubmed]
  22. Carbonic anhydrase IV on brain capillary endothelial cells: a marker associated with the blood-brain barrier. Ghandour, M.S., Langley, O.K., Zhu, X.L., Waheed, A., Sly, W.S. Proc. Natl. Acad. Sci. U.S.A. (1992) [Pubmed]
  23. Role of veins and cerebral venous pressure in disruption of the blood-brain barrier. Mayhan, W.G., Heistad, D.D. Circ. Res. (1986) [Pubmed]
  24. The transport of L-6-fluorodopa and its metabolites from blood to cerebrospinal fluid and brain. Hammerstad, J.P., Pate, B.D., Hewitt, K.A., Chan, G.L., Ruth, T.J., Calne, D.B. Ann. Neurol. (1993) [Pubmed]
  25. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid. Salen, G., Berginer, V., Shore, V., Horak, I., Horak, E., Tint, G.S., Shefer, S. N. Engl. J. Med. (1987) [Pubmed]
  26. Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Lee, S.J., McEwen, B.S. Annu. Rev. Pharmacol. Toxicol. (2001) [Pubmed]
  27. Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. Golden, P.L., Maccagnan, T.J., Pardridge, W.M. J. Clin. Invest. (1997) [Pubmed]
  28. Smoking and ischemic stroke: a role for nicotine? Hawkins, B.T., Brown, R.C., Davis, T.P. Trends Pharmacol. Sci. (2002) [Pubmed]
  29. Hippocampus-dependent learning facilitated by a monoclonal antibody or D-cycloserine. Thompson, L.T., Moskal, J.R., Disterhoft, J.F. Nature (1992) [Pubmed]
  30. Sodium transport and lithium movements across the insect blood-brain barrier. Schofield, P.K., Treherne, J.E. Nature (1975) [Pubmed]
  31. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Friedman, A., Kaufer, D., Shemer, J., Hendler, I., Soreq, H., Tur-Kaspa, I. Nat. Med. (1996) [Pubmed]
  32. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Zhu, S., Stavrovskaya, I.G., Drozda, M., Kim, B.Y., Ona, V., Li, M., Sarang, S., Liu, A.S., Hartley, D.M., Wu, d.u. .C., Gullans, S., Ferrante, R.J., Przedborski, S., Kristal, B.S., Friedlander, R.M. Nature (2002) [Pubmed]
  33. Choline and cholinergic neurons. Blusztajn, J.K., Wurtman, R.J. Science (1983) [Pubmed]
  34. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Wang, T., Town, T., Alexopoulou, L., Anderson, J.F., Fikrig, E., Flavell, R.A. Nat. Med. (2004) [Pubmed]
  35. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. Schinkel, A.H., Wagenaar, E., van Deemter, L., Mol, C.A., Borst, P. J. Clin. Invest. (1995) [Pubmed]
  36. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. Yepes, M., Sandkvist, M., Moore, E.G., Bugge, T.H., Strickland, D.K., Lawrence, D.A. J. Clin. Invest. (2003) [Pubmed]
  37. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Menegon, A., Board, P.G., Blackburn, A.C., Mellick, G.D., Le Couteur, D.G. Lancet (1998) [Pubmed]
  38. The subcellular distribution of chromosome 6-encoded dystrophin-related protein in the brain. Khurana, T.S., Watkins, S.C., Kunkel, L.M. J. Cell Biol. (1992) [Pubmed]
  39. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. Zhang, Z.G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N., Chopp, M. J. Clin. Invest. (2000) [Pubmed]
  40. Release of adenylate kinase into cerebrospinal fluid during open-heart surgery and its relation to postoperative intellectual function. Aberg, T., Ronquist, G., Tydén, H., Ahlund, P., Bergström, K. Lancet (1982) [Pubmed]
  41. Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier. Polt, R., Porreca, F., Szabò, L.Z., Bilsky, E.J., Davis, P., Abbruscato, T.J., Davis, T.P., Harvath, R., Yamamura, H.I., Hruby, V.J. Proc. Natl. Acad. Sci. U.S.A. (1994) [Pubmed]
  42. Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression. Tyler, B.M., Jansen, K., McCormick, D.J., Douglas, C.L., Boules, M., Stewart, J.A., Zhao, L., Lacy, B., Cusack, B., Fauq, A., Richelson, E. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  43. Delayed onset of brain edema and mislocalization of aquaporin-4 in dystrophin-null transgenic mice. Vajda, Z., Pedersen, M., Füchtbauer, E.M., Wertz, K., Stødkilde-Jørgensen, H., Sulyok, E., Dóczi, T., Neely, J.D., Agre, P., Frøkiaer, J., Nielsen, S. Proc. Natl. Acad. Sci. U.S.A. (2002) [Pubmed]
WikiGenes - Universities